Feng P et al. demonstrated that JX5 reduced the m6A modification level of NOTCH1 mRNA through the inhibition of IGF2BP2, subsequently decreasing NOTCH1 expression and indicating a significant therapeutic effect on T-ALL [36]. The gene discussed is NOTCH1; the disease is acute lymphoblastic leukemia.